Background: Endocrine disrupting chemicals (EDCs) are present in daily use products such as detergents, personal care products and plastics. These EDCs are associated with different metabolic and endocrine disorders. 4-Nonylphenol is a byproduct produced after the breakdown of alkylphenol ethoxylates. 4-NP shows estrogenic action and persists in the environment for a long time. There is possibility of interference in glucose homeostasis and involvement in developing Type Diabetes Mellitus (T2DM) by interfering with the signalling pathways related to estrogen and insulin. Objective: In the present study molecular interaction between 4-NP and target proteins related to estrogen and insulin signaling to understand its possible role in metabolic disorders such as T2DM. Methods: The present study used an in-silico molecular docking bioinformatic tool to predict the molecular interaction between 4-NP and nine target proteins related to estrogen and insulin signalling pathways. Nine target proteins were selected: ESR1, ESR2, GPER, INSR, IRS1, IRS2, PI3K, AKT, and GLUT-4 and binding affinities were determined by using AlphaFold, AutoDock Vina, and Maestro. Furthermore, AlphaFold and LigPlot were used to determine hydrogen bonds and hydrophobic interactions. Results: The docking analysis showed that the binding affinity of the ligand ranged from -6.2 to -9.1 kcal/mol. The strongest binding has been observed for PI3K and GLUT-4, indicating that the ligand might interfere with insulin-induced glucose uptake. The presence of stable complexes was confirmed by the presence of 1-3 hydrogen bonds and hydrophobic interactions. The binding of the ligand to ESR1, ESR2, and GPER (binding affinity of around -7.5 to -8.0 kcal/mol) also indicated that the ligand might modulate the function of estrogen receptors and the role of β cells in the pancreas. Conclusions: The study suggests that the ligand 4-NP might strongly interact with target proteins that play important roles in the regulation of estrogen and insulin signalling.